Good morning. Here is what caught our eye in the last 24 hours, from a record-breaking quarter in AI chips to a Canadian poet taking home the Nobel Prize.
Samsung just forecast the biggest quarterly profit any tech company has ever made. The Korean giant estimated operating profit of 107.4 trillion won, about $80 billion, for the July to September quarter, a nearly nine-fold jump from a year ago and its fourth straight record quarter. Memory chips for AI data centers are doing the heavy lifting, with the chip shortage now expected to run into 2028.
Why it matters: the super intelligence buildout is now showing up in the largest numbers the industry has ever posted.
Mistral launched a trillion-parameter open model called Le Chonk. The French lab’s Mistral Large 4 activates only 49 billion of its 1 trillion parameters per token, keeping serving costs low while claiming the best open-weight results of any Western lab. The API preview is live now and the full model weights follow on October 27.
Why it matters: Europe is making its case that the future of super intelligence does not have to run on closed American APIs.
Anne Carson won the Nobel Prize in Literature. The Canadian poet was honored for her bold and inventive body of work, which the Swedish Academy praised for creating new forms for contemporary literature in playful dialogue with the classical tradition.
Why it matters: a poet who reimagined what poetry can do just got the world’s biggest literary stage.
The chemistry Nobel cracked a century-old mirror mystery. Henri B. Kagan of France and Kenso Soai of Japan won for their work on homochirality, explaining how nature’s molecules came to favor one mirror image over the other, a discovery that has reshaped how pharmaceuticals are designed.
Why it matters: the drugs of the future are built on the chemistry these two unlocked.
A new pneumonia vaccine for older adults passed its biggest trial. Vaxcyte’s VAX-31, designed to cover 31 strains of the pneumococcus bacteria behind roughly 95% of invasive disease in adults over 50, met its goals in a Phase 3 trial of more than 3,500 adults.
Why it matters: a single shot could soon cover far more of the pneumonia strains that still hospitalize millions each year.
Birmingham’s Literature Festival opens today. The five-day festival turns England’s second city into a book lover’s destination from October 8 to 12, part of a growing autumn wave of literary tourism drawing travelers to festivals across the UK, Australia and Canada.
Why it matters: the best trips feed the mind too, and literary festivals are becoming a travel category of their own.
That is the world in three minutes. We will be back tomorrow with the next edition.
